<DOC>
	<DOCNO>NCT01214174</DOCNO>
	<brief_summary>This study test efficacy safety IBI-10090 treatment ocular inflammation cataract surgery .</brief_summary>
	<brief_title>Efficacy Safety Study IBI-10090 Cataract Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<criteria>Male female patient 40 year age schedule unilateral cataract surgery ( phacoemulsification extracapsular extraction ) posterior chamber intraocular lens implantation . Patients use ocular , topical , oral corticosteroid within 7 day prior Day 0 . Patients use topical ocular NSAIDs study eye within 15 day prior screen . Patients sign intraocular inflammation either eye screening . Patients receive prior intravitreal injection study eye .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>cataract</keyword>
	<keyword>inflammation</keyword>
</DOC>